Agalsidase alfa infusions for Belfast homecare come from Sciensus
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct award
- 29 September 2026 to 30 September 2028
Belfast Health and Social Care Trust is buying agalsidase alfa from Sciensus Pharma Services Limited, supplied as a homecare service. The medicine is a concentrate for infusion, in 3.5 mL vials holding 3.5 mg each.
The trust awarded the contract directly to Sciensus in September 2026, without a competition. The two-year contract is worth £670,000 and runs to September 2028.
Contract ends September 2028
- What
- Homecare medicines services
- Supplier
- Sciensus Pharma Services Limited
- Value
- £670,000
- How it was bought
- Direct award
- Dates and next
- Sep 2026 to Sep 2028